company background image
CNMD logo

CONMED NYSE:CNMD Stock Report

Last Price

US$76.44

Market Cap

US$2.3b

7D

3.2%

1Y

-39.7%

Updated

31 May, 2024

Data

Company Financials +

CNMD Stock Overview

A medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide.

CNMD fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance2/6
Financial Health3/6
Dividends4/6

CONMED Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CONMED
Historical stock prices
Current Share PriceUS$76.44
52 Week HighUS$138.47
52 Week LowUS$61.05
Beta1.37
1 Month Change11.85%
3 Month Change-4.39%
1 Year Change-39.72%
3 Year Change-43.31%
5 Year Change-6.70%
Change since IPO3,722.00%

Recent News & Updates

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Recent updates

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28
Is CONMED (NYSE:CNMD) Using Too Much Debt?

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18
Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30
CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22
Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08
Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17
These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14
Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18
At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11
CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

ConMed: Fairly Priced At Pre-Pandemic Market Cap

Sep 21

CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

Sep 03
CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Aug 18
CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

CONMED declares $0.20 dividend

Aug 11

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?

Jul 20
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?

We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt

Jun 23
We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt

Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

Jun 10
Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

Estimating The Fair Value Of CONMED Corporation (NYSE:CNMD)

May 25
Estimating The Fair Value Of CONMED Corporation (NYSE:CNMD)

Shareholder Returns

CNMDUS Medical EquipmentUS Market
7D3.2%-1.2%-1.2%
1Y-39.7%1.8%21.5%

Return vs Industry: CNMD underperformed the US Medical Equipment industry which returned 1.8% over the past year.

Return vs Market: CNMD underperformed the US Market which returned 21.5% over the past year.

Price Volatility

Is CNMD's price volatile compared to industry and market?
CNMD volatility
CNMD Average Weekly Movement6.0%
Medical Equipment Industry Average Movement7.8%
Market Average Movement5.8%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market2.9%

Stable Share Price: CNMD has not had significant price volatility in the past 3 months.

Volatility Over Time: CNMD's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19704,000Curt Hartmanwww.conmed.com

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.

CONMED Corporation Fundamentals Summary

How do CONMED's earnings and revenue compare to its market cap?
CNMD fundamental statistics
Market capUS$2.33b
Earnings (TTM)US$82.35m
Revenue (TTM)US$1.26b

28.6x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CNMD income statement (TTM)
RevenueUS$1.26b
Cost of RevenueUS$562.66m
Gross ProfitUS$698.89m
Other ExpensesUS$616.54m
EarningsUS$82.35m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.67
Gross Margin55.40%
Net Profit Margin6.53%
Debt/Equity Ratio115.7%

How did CNMD perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

30%

Payout Ratio

Does CNMD pay a reliable dividends?

See CNMD dividend history and benchmarks
When do you need to buy CNMD by to receive an upcoming dividend?
CONMED dividend dates
Ex Dividend DateJun 14 2024
Dividend Pay DateJul 05 2024
Days until Ex dividend13 days
Days until Dividend pay date34 days

Does CNMD pay a reliable dividends?

See CNMD dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.